Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 252, pseudogene (RNU6-252P)
- Target
- RNU6-252P
- Molecular classification
- Pseudogene, Small nuclear RNA pseudogene
01
Overview
RNA, U6 small nuclear 252, pseudogene (RNU6-252P) is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) family, annotated as a non-coding RNA locus in the human genome. This gene is a member of the U6 snRNA pseudogenes, which are generated via retrotransposition mechanisms in the genome. U6 snRNA plays a role in the spliceosome complex for pre-mRNA splicing, but RNU6-252P, as a pseudogene, is not known to be expressed as a functional RNA or protein and has no established biological function or disease association[1][2]. Pseudogenes such as RNU6-252P arise through ancestral gene duplication or retrotransposition events, and are typically transcriptionally inactive[2]. There are no known drugs, disease associations, or use as a biomarker related to this specific pseudogene, and it is not a therapeutic target[1].
- Other names
- RNU6-252PRNA, U6 small nuclear 252 pseudogene
02
Biological functions
PseudogeneDerived from a non-coding RNA involved in splicing, but does not have a known function itself
Beyond the preview
Go deeper on RNA, U6 small nuclear 252, pseudogene (RNU6-252P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 252, pseudogene (RNU6-252P).